DUBLIN--(BUSINESS WIRE)--The "Global IL-17 Biologics Market (2023 Edition): Analysis By Indication, By Drug (Secukinumab, Ixekizumab, Bimekizumab, Brodalumab), By Region, By Country: Market Insights ...
Women with psoriasis show shorter drug survival for biologics, including IL-17/23 inhibitors, due to lower satisfaction and more frequent adverse events. The study used the Dutch BioCAPTURE registry ...
Researchers have shown that a novel antibody generated to target an 'essential amino acid sequence’ of both interleukin-17A and F has greater activity and potentially fewer side effects than existing ...
SAN FRANCISCO and SUZHOU, China, May 28, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
Authors of an observational cohort study published in the Journal of the European Academy of Dermatology and Venereology investigated the efficacy of interleukin-17 inhibitors (IL-17i) for the ...
BIRMINGHAM, England, Aug. 15, 2023 /PRNewswire/ -- University of Birmingham Enterprise Ltd, 15 August 2023: Research has shown that a novel antibody generated to target an 'essential amino acid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback